375 related articles for article (PubMed ID: 35164285)
21. Studies on the cross-interaction between hIAPP and Aβ
Pang B; Zhuang X; Bian X; Liu S; Liu Z; Song F
J Mass Spectrom; 2020 Oct; 55(10):e4643. PubMed ID: 32893436
[TBL] [Abstract][Full Text] [Related]
22. Myricetin protects pancreatic β-cells from human islet amyloid polypeptide (hIAPP) induced cytotoxicity and restores islet function.
Dubey R; Kulkarni SH; Dantu SC; Panigrahi R; Sardesai DM; Malik N; Acharya JD; Chugh J; Sharma S; Kumar A
Biol Chem; 2021 Jan; 402(2):179-194. PubMed ID: 33544469
[TBL] [Abstract][Full Text] [Related]
23. Combined in silico approaches for the identification of novel inhibitors of human islet amyloid polypeptide (hIAPP) fibrillation.
Patel P; Parmar K; Vyas VK; Patel D; Das M
J Mol Graph Model; 2017 Oct; 77():295-310. PubMed ID: 28917147
[TBL] [Abstract][Full Text] [Related]
24. Linking hIAPP misfolding and aggregation with type 2 diabetes mellitus: a structural perspective.
Hassan S; White K; Terry C
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35475576
[TBL] [Abstract][Full Text] [Related]
25. All-atom structure ensembles of islet amyloid polypeptides determined by enhanced sampling and experiment data restraints.
Su X; Wang K; Liu N; Chen J; Li Y; Duan M
Proteins; 2019 Jul; 87(7):541-550. PubMed ID: 30803034
[TBL] [Abstract][Full Text] [Related]
26. UCHL1 deficiency exacerbates human islet amyloid polypeptide toxicity in β-cells: evidence of interplay between the ubiquitin/proteasome system and autophagy.
Costes S; Gurlo T; Rivera JF; Butler PC
Autophagy; 2014 Jun; 10(6):1004-14. PubMed ID: 24879150
[TBL] [Abstract][Full Text] [Related]
27. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
Westermark P; Andersson A; Westermark GT
Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
[TBL] [Abstract][Full Text] [Related]
28. Pancreastatin induces islet amyloid peptide aggregation in the pancreas, liver, and skeletal muscle: An implication for type 2 diabetes.
Reza MI; Syed AA; Kumariya S; Singh P; Husain A; Gayen JR
Int J Biol Macromol; 2021 Jul; 182():760-771. PubMed ID: 33862075
[TBL] [Abstract][Full Text] [Related]
29. Protein aggregates and proteostasis in aging: Amylin and β-cell function.
Press M; Jung T; König J; Grune T; Höhn A
Mech Ageing Dev; 2019 Jan; 177():46-54. PubMed ID: 29580826
[TBL] [Abstract][Full Text] [Related]
30. Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism.
Mukherjee A; Morales-Scheihing D; Salvadores N; Moreno-Gonzalez I; Gonzalez C; Taylor-Presse K; Mendez N; Shahnawaz M; Gaber AO; Sabek OM; Fraga DW; Soto C
J Exp Med; 2017 Sep; 214(9):2591-2610. PubMed ID: 28765400
[TBL] [Abstract][Full Text] [Related]
31. On the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP Peptides.
Tomasello MF; Sinopoli A; Pappalardo G
J Diabetes Res; 2015; 2015():918573. PubMed ID: 26582441
[TBL] [Abstract][Full Text] [Related]
32. Type 2 diabetes as a protein misfolding disease.
Mukherjee A; Morales-Scheihing D; Butler PC; Soto C
Trends Mol Med; 2015 Jul; 21(7):439-49. PubMed ID: 25998900
[TBL] [Abstract][Full Text] [Related]
33. Matrix Metalloproteinase-9 Protects Islets from Amyloid-induced Toxicity.
Meier DT; Tu LH; Zraika S; Hogan MF; Templin AT; Hull RL; Raleigh DP; Kahn SE
J Biol Chem; 2015 Dec; 290(51):30475-85. PubMed ID: 26483547
[TBL] [Abstract][Full Text] [Related]
34. Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.
Brender JR; Salamekh S; Ramamoorthy A
Acc Chem Res; 2012 Mar; 45(3):454-62. PubMed ID: 21942864
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms for the destabilization of model membranes by islet amyloid polypeptide.
Divakara MB; Martinez D; Ravi A; Bhavana V; Ramana V; Habenstein B; Loquet A; Santosh MS
Biophys Chem; 2019 Feb; 245():34-40. PubMed ID: 30576976
[TBL] [Abstract][Full Text] [Related]
36. Prion-Like Protein Aggregates and Type 2 Diabetes.
Mukherjee A; Soto C
Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28159831
[TBL] [Abstract][Full Text] [Related]
37. Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II Diabetes.
Milardi D; Gazit E; Radford SE; Xu Y; Gallardo RU; Caflisch A; Westermark GT; Westermark P; Rosa C; Ramamoorthy A
Chem Rev; 2021 Feb; 121(3):1845-1893. PubMed ID: 33427465
[TBL] [Abstract][Full Text] [Related]
38. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
[TBL] [Abstract][Full Text] [Related]
39. Defining the molecular basis of amyloid inhibitors: human islet amyloid polypeptide-insulin interactions.
Susa AC; Wu C; Bernstein SL; Dupuis NF; Wang H; Raleigh DP; Shea JE; Bowers MT
J Am Chem Soc; 2014 Sep; 136(37):12912-9. PubMed ID: 25144879
[TBL] [Abstract][Full Text] [Related]
40. Genistein: A Dual Inhibitor of Both Amyloid β and Human Islet Amylin Peptides.
Ren B; Liu Y; Zhang Y; Cai Y; Gong X; Chang Y; Xu L; Zheng J
ACS Chem Neurosci; 2018 May; 9(5):1215-1224. PubMed ID: 29432676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
